诊断和管理渐进性皮层基底综合征
Claire Delpirou Nouh1, Kyan Younes1
1Department of Neurology, Division of Behavioral Neurology, Stanford Neuroscience Health Center, 453 Quarry Road, Palo Alto, CA 94304, USA.
Current treatment options in neurology
|January 31, 2025
概括
皮层骨干综合征 (CBS) 呈现出不同的临床,放射和神经病理特征,使诊断和治疗复杂化. 生物标志物和理解疾病异质性的进展为这些神经退行性蛋白质病变提供了针对性治疗的希望.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 皮层骨干综合征 (CBS) 呈现出显著的异质性,使准确的诊断和治疗策略复杂化.
- 虽然皮层骨干退化 (CBD) 是最常见的原因,但CBS可能源于各种神经退化和神经免疫疾病.
- 准确的诊断对于有效的管理和参与临床试验至关重要.
研究的目的:
- 审查CBS的临床,放射和神经病理异质性.
- 探索临床表现和诊断线索,以确定潜在的病因.
- 讨论当前和新兴的生物标志物和CBS的治疗选择.
主要方法:
- 在CBS中对临床表现,放射学发现和神经病理学数据的文献综述.
- 分析当前和新兴的流体和神经成像生物标志物用于CBS诊断.
- 对CBS和相关蛋白质病变的现有和潜在的未来治疗策略的检查.
主要成果:
- 综合神经系统有多种不同的临床,放射和神经病理特征,经常与其他神经退行性疾病重叠.
- 越来越复杂的液体和神经成像生物标志物正在为临床使用提供.
- 了解CBS多样性和生物标志物开发的进展为新疗法带来了乐观的预期.
结论:
- 解决CBS的异质性对于准确的诊断和改善患者结果至关重要.
- 生物标志物开发是推动早期检测和个性化治疗CBS的关键.
- 了解CBS的进步为针对潜在病理的新型治疗干预铺平了道路.
相关概念视频
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Chronic Pancreatitis II: Collaborative Care
60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
60
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437


